HIGHLIGHTS
- who: Weiliang Tian from the Department of General Surgery, Jinling Hospital, Nanjing, Jiangsu, China have published the paper: Effect of postoperative utilization of somatostatin on clinical outcome after definitive surgery for duodenal fistula, in the Journal: (JOURNAL)
- what: The aim of this study is to validate the hypothesis above and evaluate the effect of postoperative use of somatostatin on the recurrent DF after the definitive surgery.
SUMMARY
Among those various effects of somatostatin, the inhibition of digestive juice secretion, and reduction of the pressure in the digestive tract are currently exploited . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.